BROOKS LABORATORIES
|
BROOKS LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Profit Before Tax | ₹-20 Cr | ₹-38 Cr | ₹-24 Cr | ₹-8.99 Cr |
Adjustment | ₹23 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr |
Changes In working Capital | ₹-13 Cr | ₹11 Cr | ₹-24 Cr | ₹7.37 Cr |
Cash Flow after changes in Working Capital | ₹-9.88 Cr | ₹-14 Cr | ₹-37 Cr | ₹8.66 Cr |
Cash Flow from Operating Activities | ₹-9.68 Cr | ₹-14 Cr | ₹-37 Cr | ₹4.46 Cr |
Cash Flow from Investing Activities | ₹0.18 Cr | ₹0.49 Cr | ₹-25 Cr | ₹-5.13 Cr |
Cash Flow from Financing Activities | ₹9.60 Cr | ₹11 Cr | ₹64 Cr | ₹1.16 Cr |
Net Cash Inflow / Outflow | ₹0.10 Cr | ₹-2.58 Cr | ₹1.72 Cr | ₹0.49 Cr |
Opening Cash & Cash Equivalents | ₹0.02 Cr | ₹2.61 Cr | ₹0.88 Cr | ₹0.40 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹0.13 Cr | ₹0.02 Cr | ₹2.61 Cr | ₹0.88 Cr |
Compare Cashflow Statement of peers of BROOKS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BROOKS LABORATORIES | ₹451.0 Cr | 8.2% | 19.7% | 27.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹436,103.0 Cr | 1% | 0.7% | 47.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,540.0 Cr | -1.1% | -5.8% | 61.7% | Stock Analytics | |
CIPLA | ₹119,196.0 Cr | 0.3% | -1.8% | 19.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,752.0 Cr | 6% | 11.8% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,041.2 Cr | -1.5% | -0.1% | 47% | Stock Analytics |
BROOKS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BROOKS LABORATORIES | 8.2% |
19.7% |
27.4% |
SENSEX | -2.7% |
-0.8% |
9.9% |
You may also like the below Video Courses